Thrombostatin cont-1

Thrombostatin cont-1 is an analogue of thrombostatin, which is a a bradykinin metabolite. Thrombostatin could decrease platelet activation in the canine carotid artery model of balloon angioplasty (BA) injury[1].

Product Specifications

CAS Number

[929555-19-1]

UNSPSC

12352209

Target

Bradykinin Receptor

Type

Peptides

Related Pathways

GPCR/G Protein

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/thrombostatin-cont-1.html

Solubility

10 mM in DMSO

Smiles

O=C([C@H]1N(CCC1)C([C@@H](N)CCC(N)=O)=O)N[C@H](C(N[C@@H](CO)C(N[C@@H](CCC(N)=O)C(N[C@@H](CS)C(N[C@@H](CO)C(N[C@@H](C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CS)C(NCC(N[C@@H](CC(O)=O)C(NCC(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(O)=O)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC2=CNC3=CC=CC=C23

Molecular Formula

C87H142N34O29S2

Molecular Weight

2192.40

References & Citations

[1]Prieto AR, et al. Thrombostatin, a bradykinin metabolite, reduces platelet activation in a model of arterial wall injury. Cardiovasc Res. 2002 Mar;53 (4) :984-92. |[2]Karagiannis ED, et al. Anti-angiogenic peptides identified in thrombospondin type I domains. Biochem Biophys Res Commun. 2007 Jul 20;359 (1) :63-9.